Industry overview Pharmaceutical sector is an important industry of any modern day economic power. Pharmaceutical industry in India has a very humble past. After independence‚ development of pharmaceutical industry was one of the top agenda of government along with steel and manufacturing industry. The market was protected against competition for a long period of time by giving incentives to small firms‚ license-raj etc. Today the Indian pharmaceutical industry is the front-runner science-based
Premium Pharmaceutical industry Generic drug Food and Drug Administration
RFID in Pharmaceutical Industry In 2004‚ US Food and Drug Administration (FDA) has called for the implementation of RFID technology to track the distribution of prescription drugs in order to protect the medical supply chain from counterfeit drugs by 2007. Initially‚ California State Board of Pharmacy has mandated RFID technology but later extended implementation date until 2015. In 2007‚ Kalorama Information predicted in a report that market for RFID solutions in pharmaceutical industry would
Premium RFID Pharmacology Pharmaceutical industry
R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon’s proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1998 Unilever inks a deal with ICI to sell
Premium Pharmaceutical industry Marketing Pharmacology
Bangladesh Pharmaceutical Industry By Sarker Imran‚ RRU‚ BC‚ Canada | | There are several sectors on which Bangladesh can be proud of and undoubtedly the pharmaceutical sector is one of these sectors‚ rather it is the sector‚ which is the second-largest contributor to the government exchequer. There are about 231 companies in this sector and the approximate total market size is about Taka 76‚500 million per year of which about 97% of the total requirement of medicines is created by the
Premium World Trade Organization International trade General Agreement on Tariffs and Trade
Objective of the report: The Bangladesh paradox has been one of surprising economic resilience in the face of natural disasters‚ poor governance and political volatility. However‚ a key challenge is whether Bangladesh can move away from an economy that is an impressive underdog‚ to one that can truly join the ranks of the fastest growing economies in the region. Bangladesh has three key attractions for global investors and multinationals: a large base of low-cost labour‚ a large domestic
Premium Investment
The Global Pharmaceutical Industry In the pharmaceutical industry market segments can be found depending on the criteria used. For example‚ geographically there are three main market segments (the Triad accounting for 80% and with the strongest growth): The United States of America‚ Europe and Japan with the main future segment being the least developed countries. Another way of classifying the market segments that the pharmaceutical industries face is by those products directed to primary care
Premium Pharmaceutical industry Pharmacology Generic drug
Questions 1 through 7 1. On balance‚ do you think Merck is an ethical and socially responsible company? Why or why not? How about Pfizer? In my opinion‚ Merck is not an ethical and socially responsible company with introducing Vioxx into pharmaceutical market. Before the Vioxx approval by FDA‚ scientists from University of Pennsylvania found that the drug could bring some serious results such as cardiovascular‚ and there were many serious cardiovascular problems during testing on patients. However
Premium Pharmaceutical industry Pharmacology Clinical trial
The global pharmaceutical industry 1. Identify the main environmental forces currently affecting the global pharmaceutical industry. The PESTEL analysis can be used to identify the main environmental forces for the industry: Political • Stringent government regulation and powerful purchaser pressures. • Governments around the world focused on pharmaceuticals as a politically easy target in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic
Premium Pharmaceutical industry Generic drug Food and Drug Administration
1. Overview of the global pharmaceutical industry In 2003‚ Britain’s Guardian newspaper commented that‚ “on the face of it‚ the global pharmaceutical industry looks like the epitome of a modern‚ mature industry that has found a comfortable way to make profits by the billion: it ’s global‚ hi-tech‚ and has the ultimate customer‚ the healthcare budgets of the world ’s richest countries.” Guardian sept 2003 The global pharmaceutical industry is nowadays made up of thousands of companies contained
Premium Generic drug Pharmaceutical industry Pharmacology
Ethics in the Pharmaceutical Industry The pharmaceutical industry started in the middle Ages‚ 18th AD in Baghdad in 754 by an Arabian. Until the early 70’s the industry grew at a small pace. In the 1970’s business began to boom and competition began to upsurge. In the 1990’s these industries and companies became more aggressive with their marketing strategies. In ’97 the U.S. Food and Drug Administration brought new rules and regulations concerning the marketing area and it required companies to
Premium Pharmacology Marketing Sales